Cargando…
Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors
Progressive supranuclear palsy (PSP) is a neurodegenerative disease that usually develops after the sixth decade of life, and the diagnosis is purely clinical except in cases of pathologically confirmed autopsies. A multidisciplinary approach to meet the patients’ complex needs is the current core t...
Autores principales: | Oyeka, Michelle, Ibilah, Terngu, Israel, Jacob, Gavito-Higuera, Jose, Salazar, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279080/ https://www.ncbi.nlm.nih.gov/pubmed/34306851 http://dx.doi.org/10.7759/cureus.15641 |
Ejemplares similares
-
The Disturbance of Gaze in Progressive Supranuclear Palsy: Implications for Pathogenesis
por: Chen, Athena L., et al.
Publicado: (2010) -
Frontrunner in Translation: Progressive Supranuclear Palsy
por: Shoeibi, Ali, et al.
Publicado: (2019) -
Gene-Environment Interactions in Progressive Supranuclear Palsy
por: Litvan, Irene, et al.
Publicado: (2021) -
Gait Analysis in Progressive Supranuclear Palsy Phenotypes
por: Picillo, Marina, et al.
Publicado: (2021) -
‘Hummingbird’ sign in progressive supranuclear palsy
por: Shukla, Rakesh, et al.
Publicado: (2009)